Palvella Therapeutics (PVLA) Assets Growth (1y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Palvella Therapeutics | 1.47 Bn | 1.21 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 232.03% |
| Dec 31, 2025 | -32.50% |
| Sep 30, 2025 | 226.17% |
| Jun 30, 2025 | 194.39% |
| Mar 31, 2025 | 169.31% |
| Dec 31, 2024 | 1,068.97% |
| Sep 30, 2024 | -65.44% |
| Jun 30, 2024 | -71.38% |
| Mar 31, 2024 | -64.14% |
| Dec 31, 2023 | -92.10% |
| Sep 30, 2023 | -40.12% |
| Jun 30, 2023 | -23.41% |
| Mar 31, 2023 | -40.01% |
| Dec 31, 2022 | -37.82% |
| Sep 30, 2022 | -39.60% |
| Jun 30, 2022 | -26.27% |
| Mar 31, 2022 | 18.42% |
| Dec 31, 2021 | 46.23% |
| Sep 30, 2021 | 41.88% |
| Jun 30, 2021 | 31.62% |
| Mar 31, 2021 | -6.45% |
| Dec 31, 2020 | -25.58% |
| Sep 30, 2020 | -0.88% |
| Jun 30, 2020 | -9.98% |
| Mar 31, 2020 | -5.55% |
| Dec 31, 2019 | -0.17% |
| Sep 30, 2019 | -23.02% |
| Jun 30, 2019 | -19.25% |
| Mar 31, 2019 | -24.35% |
| Dec 31, 2018 | 36.07% |
| Sep 30, 2018 | 53.40% |
| Jun 30, 2018 | 52.92% |
| Mar 31, 2018 | 179.98% |
| Dec 31, 2017 | 196.26% |
| Sep 30, 2017 | 126.16% |
| Jun 30, 2017 | 128.09% |
| Mar 31, 2017 | 66.31% |
| Dec 31, 2016 | 3.28% |
| Sep 30, 2016 | 20.75% |
| Jun 30, 2016 | 220.87% |
| Mar 31, 2016 | 121.79% |
| Dec 31, 2015 | 55.32% |
| Sep 30, 2015 | 16,454,675.91% |
| Jun 30, 2015 | 129,883.15% |
| Mar 31, 2015 | 8,558,421.43% |
| Dec 31, 2014 | 200.37% |
| Jun 30, 2014 | 114.19% |